Illumina, Inc. (ILMN) Price and Market Data

Illumina Inc. develops tools and services for genetic analysis across life science research and clinical laboratory applications. More than 90% of the company’s revenue comes from sequencing instruments, consumables, and related services. Its high-throughput platforms support whole-genome sequencing in humans and other large organisms, while its lower-throughput systems are designed for applications requiring smaller data outputs, including viral detection and cancer tumor screening. Illumina also offers microarrays, which accounted for 9% of 2024 sales and provide a lower-cost option for targeted genetic screening, primarily for consumer and agricultural use.